Inhalable Treatment Enhances Regeneration in Lung Fibrosis Model
A new study highlights the potential of a novel, inhalable regenerative therapy for the treatment of idiopathic pulmonary fibrosis.
University of California San Francisco
Give to UCSFA new study highlights the potential of a novel, inhalable regenerative therapy for the treatment of idiopathic pulmonary fibrosis.
A cellular therapy for epilepsy developed at UCSF has been employed for the first time in a sea lion with intractable seizures caused by ingesting toxins from algal blooms.
A new study by University of California researchers shows the promise of high-throughput DNA-sequencing technologies to improve prenatal diagnosis and pregnancy outcomes for women who have experienced an abnormal prenatal ultrasound.
UC San Francisco’s Center for Digital Health Innovation (CDHI), Fortanix, Intel, and Microsoft Azure have formed a collaboration to establish a confidential computing platform with privacy-preserving
A generous gift of $1 million from an anonymous donor recently created the Breakthrough Initiative in Type 1 Diabetes Precision Medicine and Discovery.
UCSF schools have created new courses and expanded existing curriculum that address issues of structural racism in science and health care. They take an explicitly anti-racist approach, which advocates for interventions against racism instead of merely being not racist.
In the largest study to date of COVID-19 among non-hospitalized pregnant women, researchers analyzed the clinical course and outcomes of 594 women who tested positive for the SARS-CoV-2 virus during pregnancy.
As the thousands of students head back to UCSF this fall, educators across campus have had to balance innovative distance learning opportunities with safely bringing learners back together for experiences that must take place in simulation labs, clinical settings, research labs, and more.
Risk for melanoma, the most deadly skin cancer, can be estimated long before detection of any suspicious moles, according to a UCSF scientist.
The UCSF researchers — whose work spans investigations into autism spectrum disorder (ASD), oncology, and mitochondrial disease — were among 85 awardees for the grants that the NIH says “will fund highly innovative and unusually impactful biomedical or behavioral research proposed by extraordinarily creative scientists.”
The John and Marcia Goldman Foundation, a private family foundation based in San Francisco, recently granted The Kidney Project $1 million to advance its bioartificial kidney.